Fennec Pharmaceuticals (NASDAQ:FENC) just reported results for the first quarter of 2024.
- Fennec Pharmaceuticals reported earnings per share of 41 cents. This was above the analyst estimate for EPS of 26 cents.
- The company reported revenue of $25.38 million.
- This was 34.41% better than the analyst estimate for revenue of $18.88 million.